Navigation Links
BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
Date:1/4/2008

FRANKLIN LAKES, N.J., Jan. 4 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will conduct a live webcast of its first fiscal quarter 2008 earnings conference call on Thursday, January 24, 2008 at 10:00 a.m. (ET). BD will issue a press release detailing the quarter's earnings earlier that morning.

The webcast of the conference call will be accessible through BD's website at http://www.bd.com/investors and will be available for replay through Thursday, January 31, 2008.

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people's health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit http://www.bd.com.


'/>"/>
SOURCE BD
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)... NASHVILLE, Tenn., Jan. 7 Ambulatory Services of...outh Alabama, LLC, its seventh,radiation oncology ...enture,among Gulf Coast Cancer Center - Gulf Shore...nd South Alabama Radiation Oncology, P.C., and ASA...ica, Inc. ROSA of South,Alabama will own and oper...
(Date:1/7/2009)...N ANTONIO, Jan. 7 BioMedical Enterprises, Inc. (B... on the development of orthopaedic memory metal im...eth I. Moch as its President and Chief Executive O...ill become Chief Technology Officer and continue t...roduct offerings. , , BME specializes in nitinol...
(Date:1/7/2009)...e lymphoblastic leukemia is most common pediatric ...ws) -- A mutation in leukemia cells predicts which...re likely to relapse. , The discovery, reported on...e , might lead to tests to help physicians fine-tu..."The treatment of acute lymphoblastic leukemia (AL...
(Date:1/7/2009)...cientists have identified mutations in a gene that...with acute lymphoblastic leukemia (ALL). Although ...eeded to determine how changes in the gene, called...ndings are likely to provide the basis for future ...ailure. By using a molecular test to identify thi...
Breaking Medicine News(10 mins):Health News:Ambulatory Services of America, Inc. Announces Joint Venture with Gulf Coast Cancer Centers 2Health News:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer 2Health News:Gene Governs Response to Leukemia Chemotherapy 2Health News:Gene abnormality found to predict childhood leukemia relapse 2Health News:Gene abnormality found to predict childhood leukemia relapse 3Health News:Gene abnormality found to predict childhood leukemia relapse 4
...sivity symptoms showed dramatic improvements with ...uncil’s senior education psychologist, Dr Madelein...been rated with moderate to severe ADHD and impuls...mega-3 fish and omega-6 evening primrose oil over ...
... of the storm once again, with confirmed cases of ...harashtra. Following the bird-flu notification// i...k of March, samples were sent to High Security Ani... has confirmed that seven samples had tested posit...
...ds, which consists of the some of the earth’s most...al conservation map//, and is said to be the third...tin Puta Tofinga, Minister of Environment, Lands a...ublic of Kiribati, announced the establishment of ...
... jointly by University of California, Berkeley, an...xposed to high levels of arsenic// in drinking wat...ll a victim to other lung diseases later in their ...of dying from bronchiectasis was 46 times more tha...
Other Medicine News:Health News:Phoenix Islands To Be Protected Under Global Conservation Map 2Health News:Phoenix Islands To Be Protected Under Global Conservation Map 3Health News:Arsenic in Drinking Water Predisposes Children To Lung Cancer in Later Life 2
(Date:12/17/2008)...ire/ -- PEAK Surgical, Inc., a medical,device com...stem based on a,proprietary technology, announced... (FDA) has granted the company 510(k) clearance to...d coagulation of soft tissue during,plastic and r...ogic,orthopedic, arthroscopic, spinal and neurol...
(Date:12/17/2008)...tCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH ) ...g, Ph.D., to Delcath,s Board of Directors. Dr. Co...e experience working with international and domest...scom.com/cgi-bin/prnh/20081118/NY46990LOGO ) , .... in 2006 and served as CEO. Prior to starting Co...
(Date:12/17/2008)...wire-FirstCall/ -- Neurobiological,Technologies, ...at an independent,Data Safety Monitoring Board (D...als of Viprinex(TM) for the treatment of acute isc...esult, the company has terminated further enrollme... data before evaluating the,potential for any fut...
(Date:12/16/2008)...Inflammation & Alzheimer,s Disease , , ...p Institute today announced that its researchers h...Alzheimer,s disease and have identified a potentia...ervention in this disease. The study, led by Rosk... in the American Chemical Society,s Chemical Biol...
Breaking Medicine Technology:PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in Expanded Indications 4Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 2Delcath Adds Dr. Pamela R. Contag to Its Board of Directors 3Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 2Roskamp Institute Identifies New Class of Drugs to Treat Alzheimer's Disease 3Virtual Reality Technology Finds Ready and Willing Market in Healthcare 4190 1Virtual Reality Technology Finds Ready and Willing Market in Healthcare 4190 2Childlessness Bothers Men More Than Women 4187 1Childlessness Bothers Men More Than Women 4187 2Childlessness Bothers Men More Than Women 4187 3Mice roar message 3A genetic change happens fast 895 1Mice roar message 3A genetic change happens fast 895 2Pharmaceutical Manufacturing Quality 3A Optimizing Your Internal Process for FDA Compliance 4178 1Pharmaceutical Manufacturing Quality 3A Optimizing Your Internal Process for FDA Compliance 4178 2
...n Key Lung Compartments, REINACH and BASEL, Switze...pida Ltd. today announced promising,results of "fi...ed,Human Microdose studies included a total of 19 ...dy is the first ever using Microdosing,for the det...ents.,The results showed that AR-709 achieves high...
...ar 29, 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq:...vative technology to fuel drug discovery and clini...rvous system,disorders, today announced that the c...ress on Schizophrenia Research, held from,March 28...ado.,Presentations will cover ACADIA,s two schizop...
Other Medicine Technology:Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 2Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 3Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 4Arpida Announces Promising Results of "First-In-Man" Studies With,AR-709 5ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 2ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 3ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 4ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at,the 2007 International Congress on Schizophrenia Research 5
Inquire
Adjustable speed vortex with inter-changeable heads, 110 V
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures.
Use the Mo Bio Vortex Adapter in conjunction with the Vortex Genie 2 for rapid bead beating procedures. Using the Mo Bio Vortex Adapter is an inexpensive alternative to other bead beating and Fast Pr
Medicine Products: